Literature DB >> 11822880

Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices.

Frederick Grinnell1, Chin-Han Ho.   

Abstract

Studies were carried out to test the idea that transforming growth factor beta (TGFbeta) stimulated fibroblast contraction of collagen matrices by different mechanisms depending on mechanical loading on the cells and matrix. Under mechanically unloaded conditions (floating matrices), TGFbeta stimulated contraction directly as an agonist and indirectly by preactivating cells to express the myofibroblast phenotype. Increased contraction of floating matrices by preactivated cells appeared to result in part from an autocrine mechanism. Under mechanically loaded conditions (stressed matrices), TGFbeta had no direct agonist effect on contraction. Fibroblasts preactivated to become myofibroblasts showed increased ability to transfer tension to stressed matrices, and tension persisted even after the cells' actin cytoskeleton was disrupted. Our findings are consistent with the idea that fibroblasts activated to become myofibroblasts in vitro have increased contractile activity and indicate that multiple mechanisms that differ depending on mechanical loading on the cells and matrix are involved. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822880     DOI: 10.1006/excr.2001.5445

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.

Authors:  Shaik O Rahaman; Lisa M Grove; Sailaja Paruchuri; Brian D Southern; Susamma Abraham; Kathryn A Niese; Rachel G Scheraga; Sudakshina Ghosh; Charles K Thodeti; David X Zhang; Magdalene M Moran; William P Schilling; Daniel J Tschumperlin; Mitchell A Olman
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  Heart valve and arterial tissue engineering.

Authors:  C E Sarraf; A B Harris; A D McCulloch; M Eastwood
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

3.  Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in three-dimensional culture.

Authors:  Russell A Gould; Karen Chin; Thom P Santisakultarm; Amanda Dropkin; Jennifer M Richards; Chris B Schaffer; Jonathan T Butcher
Journal:  Acta Biomater       Date:  2012-01-11       Impact factor: 8.947

4.  Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts.

Authors:  Yan Y Sanders; Pallavi Kumbla; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-07       Impact factor: 6.914

5.  Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue.

Authors:  Zeeshan H Syedain; Justin S Weinberg; Robert T Tranquillo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

Review 6.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

Review 7.  TRP functions in the broncho-pulmonary system.

Authors:  Francesco De Logu; Riccardo Patacchini; Giovanni Fontana; Pierangelo Geppetti
Journal:  Semin Immunopathol       Date:  2016-04-15       Impact factor: 9.623

Review 8.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

9.  Mechanoregulation of valvular interstitial cell phenotype in the third dimension.

Authors:  Mehmet H Kural; Kristen L Billiar
Journal:  Biomaterials       Date:  2013-11-07       Impact factor: 12.479

10.  Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase.

Authors:  Jonathan T Butcher; Russell A Norris; Stanley Hoffman; Corey H Mjaatvedt; Roger R Markwald
Journal:  Dev Biol       Date:  2006-10-04       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.